Process for preparing {3-[2(R)-[(1R)-1-[3,5-bis(trifluoromethyl) phenyl]ethoxy]-3(S)-(4-fluorophenyl)mo rpholin4-yl]methyl]-5-oxo-4,5-dihydro-[1,2,4]-tri azol-1-yl}phosphonic acid

Details for Australian Patent Application No. 2005310240 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors McNamara, James Michael; Matty, Louis; Rosen, Jonathan D.

Agent Spruson & Ferguson

Pub. Number AU-B-2005310240

PCT Pub. Number WO2006/060110

Priority 60/625,209 05.11.04 US

Filing date 3 November 2005

Wipo publication date 8 June 2006

Acceptance publication date 9 June 2011

International Classifications

C07F 9/6558 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/060110 Priority application(s): WO2006/060110

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

9 June 2011 Application Accepted

  Published as AU-B-2005310240

6 October 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005310241-System and method for fastening floor deck to semi-trailer cross members

2005310239-2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease